Ambrisentan (Letairis) and Tadalafil (Adcirca) for Pulmonary Arterial Hypertension

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2016年 / 58卷 / 1485期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2 / 4
页数：3
相关论文
共 50 条
  • [1] Ambrisentan (Letairis) for pulmonary arterial hypertension
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2007, 49 (1272): : 87 - 88
  • [2] Tadalafil (Adcirca) for Pulmonary Arterial Hypertension
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2009, 51 (1324): : 87 - 88
  • [3] Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
    Galie, N.
    Barbera, J. A.
    Frost, A. E.
    Ghofrani, H-A.
    Hoeper, M. M.
    McLaughlin, V. V.
    Peacock, A. J.
    Simonneau, G.
    Vachiery, J-L.
    Gruenig, E.
    Oudiz, R. J.
    Vonk-Noordegraaf, A.
    White, R. J.
    Blair, C.
    Gillies, H.
    Miller, K. L.
    Harris, J. H. N.
    Langley, J.
    Rubin, L. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (09): : 834 - 844
  • [4] Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
    Zhuang, Yugang
    Jiang, Bojie
    Gao, Hui
    Zhao, Wei
    HYPERTENSION RESEARCH, 2014, 37 (06) : 507 - 512
  • [5] Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
    Yugang Zhuang
    Bojie Jiang
    Hui Gao
    Wei Zhao
    Hypertension Research, 2014, 37 : 507 - 512
  • [6] Combination therapy adding tadalafil to existing ambrisentan in patients with pulmonary arterial hypertension
    Hirashiki, Akihiro
    Kondo, Takahisa
    Murohara, Toyoaki
    HYPERTENSION RESEARCH, 2014, 37 (06) : 488 - 489
  • [7] Combination therapy adding tadalafil to existing ambrisentan in patients with pulmonary arterial hypertension
    Akihiro Hirashiki
    Takahisa Kondo
    Toyoaki Murohara
    Hypertension Research, 2014, 37 : 488 - 489
  • [8] Ambrisentan(Letairis)
    刘亚婧
    宫平
    中国药物化学杂志, 2007, (06) : 408 - 408
  • [9] Ambrisentan for pulmonary arterial hypertension
    Rubin, Lewis J.
    Dufton, Christopher
    Gerber, Michael J.
    FUTURE CARDIOLOGY, 2005, 1 (04) : 425 - 432
  • [10] EFFECTIVENESS AND SAFETY OF COMBINATION THERAPY WITH AMBRISENTAN AND TADALAFIL FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION IN CHILDREN
    Issapour, Azadeh
    Crook, Sarah
    Hite, Michelle
    Rosenzweig, Erika Berman
    Frank, Benjamin
    Ivy, Dunbar
    Krishnan, Usha
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 2086 - 2086
12345